Top Markets
#1 Gravity Gravity +75.10%
#2 Galxe Galxe +57.82%
#3 TENDIES TENDIES +36.20%
#4 Railgun Railgun +36.15%
#5 Geodnet Geodnet +24.60%
#6 Fake World Assets Fake World Assets +23.71%
#7 Akedo Akedo +22.61%
#8 Injective Injective +16.93%
#9 Kinetiq Kinetiq +16.68%
#10 Collector Crypt Collector Crypt +16.50%
Coin of the day
Gravity Gravity
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Roche Holding AG Roche Holding AG

Roche Holding AG

RO
Classifica tra le azioni #36
Roche Holding AG is a global healthcare enterprise with dual focuses:... Roche Holding AG is a global healthcare enterprise with dual focuses: pharmaceuticals and diagnostics. The company maintains a significant presence in numerous countries, including its home base in Switzerland, alongside Germany, the United States, Austria, the Netherlands, the United Kingdom, France, Belgium, and various other international markets. Its pharmaceutical segment develops and supplies treatments for a wide spectrum of medical conditions, encompassing oncology, neuroscience, infectious diseases, immunology, cardiovascular and metabolic disorders, ophthalmology, and respiratory ailments, as well as specific therapies for anemia, dermatology, hemophilia, inflammatory and autoimmune conditions, and transplant patients. On the diagnostic front, Roche provides in vitro tests designed to identify various diseases like cancer, diabetes, COVID-19, hepatitis, and human papillomavirus, in addition to supplying crucial diagnostic instruments and reagents. The company was founded in Basel, Switzerland, in 1896.
Prezzo delle azioni
$484.33
Capitalizzazione di mercato
$379.69B
Variazione (1 giorno)
1.03%
Variazione (1 anno)
46.81%
Paese
CH
Scambia Roche Holding AG (RO)

Categoria

Healthcare
Utile per Roche Holding AG (RO)
Utile nel Dec 2025 TTM: $21.39B
Secondo gli ultimi rapporti finanziari di Roche Holding AG, gli utili attuali della società sono $21.39B. Nel 2019, la società ha registrato un utile di $17.17B, uguale a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Storico degli utili di Roche Holding AG dal 2019 al 2026
Utile alla fine di ogni anno
Anno Utile Cambia
2026 (TTM) $21.39B 12.07%
2021 $19.09B 11.13%
2019 $17.17B 0.00%
Utile per aziende simili o concorrenti
Azienda Utile Differenza negli utili Il paese
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
$33.59B 57.07%
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
$25.20B 17.80%
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
$8.70B -59.33%
US
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
$5.95B -72.19%
US
Novartis AG Novartis AG
Novartis AG
NOVN.SW
$16.38B -23.42%
CH